Oppenhoff's interdisciplinary team advises pharmaceutical manufacturers, biotechnology companies, hospitals, nursing homes, health insurance companies and care providers on day-to-day business operations and also focuses on M&A transactions and venture capital investments. Co-practice head Gabriele Fontane covers the corporate, M&A and private equity interface and jointly heads the team with Peter Klappich, who is a key contact for litigation and arbitration and also advises on regulatory, competition and commercial law. This is complemented by expertise in the medicinal cannabis segment, where the team recently assisted with the cross-border negotiations of supply contracts as well as the regulatory advice on related import and export issues.
Key clients
- Aphria Inc.
- Dr. August Wolff GmbH & Co. KG Arzneimittel
Work highlights
- Expert opinion for Johnson & Johnson in connection with the permissibility of the use of medical data.
- Representation of several doctors in the sale of Nephrologicum Westfalen, one of the largest independent providers of nephrology and dialysis care services in North Rhine-Westphalia, to the financial investor Adiuva.